Law Firm Announces Investigation Into Aldeyra Therapeutics
Bronstein, Gewirtz & Grossman announced an investigation involving Aldeyra Therapeutics.
Related stories
Civmec shares rise on upbeat quarterly results
Civmec shares rose on upbeat quarterly results.
M impact | EQUITY | Oct 30, 2026, 12:55 AM UTC
Hyundai Mobis Q3 Operating Profit Rises 17.15% Year on Year
M impact | EQUITY | Oct 30, 2026, 12:54 AM UTC
Firstwave Cloud Technology Reports Quarterly Revenue of A$1.90M
M impact | EQUITY | Oct 30, 2026, 12:54 AM UTC
Amazon Shares Fall 7% After Q3 Results Show Weaker Free Cash Flow
Amazon shares fell more than 7% in extended trading after third-quarter results missed expectations, fourth-quarter revenue guidance midpoint trailed projections and free cash flow
M impact | EQUITY | Oct 30, 2026, 12:51 AM UTC
Japan's Nikkei average falls 2%
M impact | EQUITY | Oct 30, 2026, 12:50 AM UTC
KPa-BM Shares Halt Trading in Hong Kong Pending Takeover Code Announcement
M impact | EQUITY | Oct 30, 2026, 12:49 AM UTC